coronaviru
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
infect
spread
global
number
death
increas
increas
number
infect
patient
aim
develop
clinic
model
predict
outcom
sever
patient
earli
epidemiolog
clinic
first
laboratori
find
admiss
sever
patient
survivor
nonsurvivor
sinofrench
new
citi
branch
tongji
hospit
use
develop
predict
model
five
machin
learn
approach
logist
regress
partial
least
squar
regress
elast
net
random
forest
bag
flexibl
discrimin
analysi
use
select
featur
predict
patient
outcom
area
receiv
oper
characterist
curv
auroc
appli
compar
model
perform
sixtyfour
sever
patient
optic
valley
branch
tongji
hospit
use
extern
valid
final
predict
model
baselin
characterist
laboratori
test
significantli
differ
survivor
nonsurvivor
four
variabl
age
highsensit
creactiv
protein
level
lymphocyt
count
ddimer
level
select
five
model
given
similar
perform
among
model
logist
regress
model
select
final
predict
model
simplic
interpret
auroc
deriv
extern
valid
set
respect
sensit
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
death
predict
patient
specif
deriv
set
valid
set
respect
use
probabl
death
cutoff
individu
risk
score
base
four
select
variabl
correspond
probabl
death
serv
index
assess
mortal
risk
patient
predict
model
freeli
avail
http
phenomicsfudaneducnriskscor
age
highsensit
creactiv
protein
level
lymphocyt
count
ddimer
level
patient
admiss
inform
patient
outcom
sever
acut
respiratori
syndrom
coronaviru
emerg
decemb
sinc
spread
nearli
countri
territori
infect
million
peopl
end
march
approxim
peopl
die
coronaviru
diseas
worldwid
accord
report
crude
fatal
rate
vari
countri
countri
march
highest
fatal
rate
observ
itali
nearli
follow
spain
nearli
iran
nearli
fatal
rate
also
heterogen
within
countri
china
highest
rate
found
wuhan
nearli
provinc
fatal
rate
epidemiolog
clinic
laboratori
featur
significantli
differ
survivor
nonsurvivor
instanc
nonsurvivor
older
survivor
dyspnea
chest
tight
disord
conscious
common
deceas
patient
recov
patient
concentr
alanin
aminotransferas
aspart
aminotransferas
creatinin
creatin
kinas
lactat
dehydrogenas
cardiac
troponin
ntermin
probrain
natriuret
peptid
ddimer
markedli
higher
nonsurvivor
survivor
ascertain
key
factor
contribut
patient
outcom
critic
reduc
mortal
risk
fatal
rate
howev
multilevel
data
may
confus
clinician
regard
featur
inde
impact
patient
outcom
current
studi
aim
develop
clinic
model
predict
mortal
risk
sever
patient
base
epidemiolog
clinic
first
laboratori
test
data
admiss
death
predict
patient
total
sever
laboratoryconfirm
nonsurvivor
admit
sinofrench
new
citi
branch
tongji
hospit
wuhan
januari
march
includ
tongji
hospit
urgent
rebuilt
assign
chines
govern
design
hospit
sever
critic
ill
patient
collect
epidemiolog
eg
age
sex
clinic
eg
fever
comput
tomographi
ct
imag
featur
first
laboratori
data
admiss
eg
highsensit
creactiv
protein
hscrp
level
patient
medic
record
figur
detail
see
tabl
valu
biochemistri
index
test
three
day
admiss
exclud
even
part
first
test
valu
left
right
truncat
eg
ddimer
use
valu
truncat
point
surrog
eg
use
ddimer
level
shown
figur
patient
miss
valu
stay
hospit
day
afflict
sever
diseas
admiss
eg
cancer
aplast
anemia
uremia
unconsci
admiss
directli
admit
intens
care
unit
icu
exclud
final
patient
includ
construct
predict
model
among
recov
discharg
die
studi
approv
nation
health
commiss
china
ethic
commiss
tongji
hospit
written
inform
consent
waiv
ethic
commiss
design
hospit
emerg
infecti
diseas
death
predict
patient
develop
predict
model
consist
three
main
stage
data
preprocess
variabl
select
model
evalu
extern
valid
figur
covari
miss
data
exclud
pair
highli
correl
variabl
correl
coeffici
remov
variabl
higher
miss
rate
variabl
zero
nearzero
varianc
also
exclud
rule
thumb
detect
predictor
zero
nearzero
varianc
follow
number
uniqu
valu
divid
sampl
size
small
set
studi
ratio
frequenc
preval
valu
frequenc
second
preval
valu
larg
set
nonnorm
distribut
continu
variabl
transform
use
boxcox
transform
miss
valu
imput
use
bag
tree
total
covari
final
includ
consid
potenti
linear
curvilinear
relationship
predictor
outcom
select
five
machin
learn
model
logist
regress
partial
least
squar
pl
regress
elast
net
model
random
forest
bag
flexibl
discrimin
analysi
fda
fit
data
tenfold
cross
valid
area
receiv
oper
characterist
curv
auroc
use
measur
model
perform
select
tune
paramet
perform
model
base
full
data
shown
tabl
logist
regress
use
stepwis
backward
select
variabl
variabl
import
assess
use
absolut
valu
tstatist
pl
regress
variabl
import
measur
base
weight
sum
death
predict
patient
absolut
regress
coeffici
weight
function
reduct
sum
squar
across
number
pl
compon
comput
separ
outcom
therefor
contribut
coeffici
weight
proport
reduct
sum
squar
elast
net
model
select
variabl
coeffici
shrink
random
forest
model
predict
accuraci
outofbag
portion
data
record
tree
procedur
perform
permut
predictor
variabl
differ
two
accuraci
averag
across
tree
normal
standard
error
bag
fda
model
seri
cutoff
appli
predictor
data
predict
class
auroc
sensit
specif
comput
cutoff
trapezoid
rule
use
comput
auroc
use
measur
variabl
import
top
import
variabl
select
five
model
shown
figur
e
chose
intersect
set
variabl
four
variabl
final
select
age
hscrp
lymphocyt
count
ddimer
five
model
refit
use
four
variabl
auroc
sensit
specif
obtain
cross
valid
use
evalu
model
perform
total
sever
laboratoryconfirm
patient
survivor
nonsurvivor
admit
optic
valley
branch
tongji
hospit
wuhan
includ
extern
valid
set
use
select
predict
model
predict
probabl
death
patient
auroc
sensit
specif
use
evalu
model
perform
cost
curv
predict
model
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
death
predict
patient
cost
curv
graphic
techniqu
visual
perform
expect
cost
classifi
rang
possibl
class
distribut
cutoff
herein
defin
cost
fals
neg
three
time
fals
posit
cutoff
predict
death
rang
fals
neg
rate
fals
posit
rate
calcul
confus
matrix
predict
model
use
differ
cutoff
visual
curv
normal
true
posit
rate
normal
expect
cost
normal
true
posit
rate
calcul
normal
expect
cost
calcul
covari
includ
predict
model
shown
tabl
gener
characterist
significantli
differ
survivor
nonsurvivor
nonsurvivor
like
male
older
survivor
proport
death
predict
patient
basic
condit
eg
diabet
hypertens
compar
two
sampl
symptom
diseas
onset
nonsurvivor
report
loss
appetit
dyspnea
product
cough
often
survivor
laboratori
test
index
also
significantli
differ
deceas
patient
recov
exampl
white
cell
count
higher
nonsurvivor
survivor
convers
lymphocyt
count
nearli
twice
high
survivor
nonsurvivor
nonsurvivor
liver
kidney
function
injuri
specif
concentr
liver
enzym
urea
creatinin
markedli
higher
nonsurvivor
wherea
albumin
level
estim
glomerular
filtrat
rate
lower
sampl
level
inflammatori
factor
higher
nonsurvivor
survivor
circul
level
hscrp
ddimer
nearli
higher
nonsurvivor
survivor
respect
process
model
develop
detail
method
section
figur
auroc
obtain
cross
valid
use
compar
perform
five
select
predict
model
figur
consid
minor
differ
auroc
logist
regress
model
random
forest
bag
fda
select
logist
regress
model
final
model
simplic
high
interpret
auroc
logist
regress
model
base
age
hscrp
lymphocyt
count
ddimer
combin
individu
shown
tabl
model
perform
significantli
increas
use
four
variabl
combin
figur
auroc
extern
valid
set
sensit
specif
predict
death
use
probabl
death
cutoff
figur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
death
predict
patient
shown
figur
death
probabl
curvilinearli
associ
normal
figur
show
cost
curv
cutoff
rang
death
probabl
ie
normal
lowest
expect
cost
observ
use
cutoff
death
probabl
increas
ie
normal
lowest
expect
cost
observ
cutoff
death
probabl
reach
nearli
ie
normal
around
lowest
expect
cost
observ
cutoff
contribut
select
variabl
assess
use
logist
regress
model
regress
coeffici
calcul
weight
predictor
risk
score
therefor
calcul
denot
regress
intercept
observ
valu
coeffici
respect
th
predictor
figur
probabl
death
calcul
via
figur
show
risk
score
survivor
nonsurvivor
approxim
normal
distribut
sshape
correl
pattern
risk
score
probabl
death
shown
figur
mortal
risk
exce
risk
score
facilit
applic
predict
model
also
develop
accompani
web
tool
http
phenomicsfudaneducnriskscor
reader
freeli
access
websit
input
valu
hscrp
age
lymphocyt
count
ddimer
predict
mortal
risk
confid
interv
patient
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
death
predict
patient
discuss
current
worldwid
pandem
number
laboratoryconfirm
patient
well
number
relat
death
continu
increas
fatal
rate
might
increas
along
increas
number
infect
peopl
even
advanc
healthcar
system
like
overwhelm
chines
center
diseas
control
prevent
recent
report
confirm
case
classifi
mild
moder
approxim
classifi
sever
critic
even
assum
fatal
rate
sever
critic
ill
case
number
induc
death
consider
enorm
number
infect
patient
identifi
patient
high
risk
death
critic
patient
manag
reduc
fatal
rate
clinic
predict
model
studi
took
full
advantag
multifacet
data
patient
admiss
predict
outcom
four
variabl
ie
age
hscrp
ddimer
lymphocyt
count
select
use
fit
logist
regress
model
predict
perform
model
accept
deriv
set
extern
valid
set
also
develop
web
tool
implement
predict
model
clinician
use
web
tool
predict
mortal
risk
patient
earli
patient
rel
higher
probabl
death
eg
intervent
could
adopt
earlier
stage
clinician
reduc
mortal
risk
recent
studi
older
age
ddimer
level
greater
gml
higher
sequenti
organ
failur
assess
sofa
score
admiss
report
associ
higher
odd
inhospit
death
fatal
rate
highli
heterogen
among
patient
differ
age
instanc
overal
case
fatal
rate
china
estim
age
year
old
substanti
increas
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
death
predict
patient
age
year
old
among
age
year
old
older
rate
high
likewis
itali
fatal
rate
increas
among
patient
age
year
old
among
age
year
old
approxim
italian
popul
age
year
older
percentag
may
explain
part
itali
higher
casefat
rate
compar
countri
studi
age
select
key
factor
predict
model
agedepend
deterior
immunolog
compet
eg
bcell
tcell
defici
often
refer
immunosenesc
excess
product
type
cytokin
could
lead
defici
control
viral
replic
prolong
proinflammatori
respons
potenti
lead
poor
outcom
studi
deceas
patient
persist
sever
lymphopenia
compar
recov
patient
lymphocyt
count
select
incorpor
predict
model
defect
function
lymphocyt
agedepend
associ
inflamm
level
addit
hscrp
commonli
use
inflammatori
biomark
clinic
select
predict
model
patient
higher
level
hscrp
admiss
deem
higher
level
inflamm
studi
found
hscrp
level
time
higher
nonsurvivor
survivor
although
level
inflammatori
biomark
ferritin
erythrocyt
sediment
rate
also
elev
nonsurvivor
select
incorpor
predict
model
omiss
might
explain
higher
miss
rate
covari
high
correl
hscrp
coagul
disord
character
elev
prothrombin
time
ddimer
level
also
frequent
observ
among
patient
studi
prothrombin
time
ddimer
significantli
higher
nonsurvivor
survivor
higher
valu
suggest
increas
risk
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
death
predict
patient
dissemin
intravascular
coagul
one
frequent
diagnos
complic
among
later
stage
studi
number
strength
first
knowledg
first
studi
predict
outcom
sever
patient
base
comprehens
data
second
ensur
robust
predict
model
enforc
strict
inclus
exclus
criteria
includ
particip
studi
data
third
use
advanc
model
strategi
select
featur
construct
predict
model
final
model
simpl
includ
four
variabl
highli
interpret
model
linear
model
effect
predictor
reflect
regress
coeffici
moreov
extern
valid
final
predict
model
fourth
develop
accompani
web
tool
facilit
applic
predict
model
clinician
studi
also
limit
first
predict
model
construct
base
rel
small
sampl
size
interpret
find
might
limit
second
due
retrospect
studi
design
laboratori
test
perform
patient
might
delet
data
preprocess
procedur
role
might
underestim
predict
patient
outcom
third
patient
sometim
transfer
hospit
two
branch
tongji
hospit
although
exclud
patient
meet
inclus
criteria
valu
laboratori
test
might
bias
prior
antivir
treatment
patient
final
patient
deriv
set
valid
set
tongji
hospit
one
hospit
high
level
medic
care
china
critic
ill
patient
recov
might
die
hospit
suboptim
typic
level
medic
care
cutoff
predict
death
eg
defin
patient
probabl
death
highrisk
patient
set
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
death
predict
patient
summari
use
avail
clinic
data
develop
robust
machin
learn
model
predict
outcom
patient
earli
model
accompani
web
applic
import
clinician
identifi
patient
high
risk
death
therefor
critic
prevent
control
compet
interest
author
none
compet
interest
declar
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
p
l
g
r
r
e
l
e
w
h
e
u
n
p
h
g
e
n
e
f
e
p
n
e
l
e
r
l
p
e
n
c
l
n
c
l
n
f
e
c
u
e
e
n
f
f
c
l
p
u
b
l
c
n
f
h
e
n
f
e
c
u
e
e
c
e
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
categor
variabl
shown
frequenc
continu
variabl
follow
normal
approxim
normal
distribut
shown
mean
standard
deviat
continu
variabl
follow
normal
distribut
shown
median
interquartil
rang
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
death
predict
patient
termin
probrain
natriuret
peptid
hscrp
highsensit
creactiv
protein
cre
creatinin
alt
alanin
aminotransferas
interleukin
lym
lymphocyt
count
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
